UNITED STATES SECURITIES AND EXCHANGE COMMISSION

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

_______________

FORM 8-K

CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

~~Pursuant~~Date toof ~~Section~~Report ~~13 or 15~~(d)Date of ~~the~~earliest ~~Securities~~event ~~Exchange~~reported) ~~Act~~June 3, of2010 ~~1934~~(June 3, 2010)

Date of Report (Date of earliest event reported) April 19, 2010 (April 13, 2010)

____________

DIALYSIS CORPORATION OF AMERICA

(Exact name of registrant as specified in its charter)

Florida	0-8527	59-1757642
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer File Number)
(State or other jurisdiction	(Commission	(IRS Employer
of incorporation)	File Number)	File Number)

1302 Concourse Drive, Suite 204, Linthicum, MD		21090
(Address of principal executive offices)k		(Zip Code)
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (410) 694-0500

____________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

~~Item~~Introductory ~~1.01 Entry into a Material Definitive Agreement~~Note

On June 3, 2010, pursuant to the terms of the previously announced Agreement and Plan of Merger, dated as of April 13, 2010 (the “Merger Agreement”), by and among U.S. Renal Care, Inc., a Delaware corporation (“USRC”), Urchin Merger Sub, Inc., a Florida corporation and wholly owned subsidiary of USRC (“Merger Sub”), and Dialysis Corporation of America, a Florida corporation (the “Company”), USRC caused Merger Sub to merge with and into the Company (the “Merger”) in accordance with Florida law, which authorizes the completion of the Merger without a vote or meeting of the shareholders of the Company. The Company was the surviving corporation in the Merger and continues to exist as a wholly owned subsidiary of USRC.

OnItem ~~April 13, 2010, Dialysis Corporation of America, a Florida corporation (the “Company”), U~~1.S.02 ~~Renal~~Termination ~~Care, Inc., a Delaware corporation (“Parent”), and Urchin Merger Sub, Inc., a Florida corporation and a wholly owned subsidiary~~ of Parent (“Merger Sub”), entered into an Agreement and Plan of Merger (the “Merger Agreement”), pursuant to which, and subject to the terms and conditions set forth therein, Merger Sub will commence a ~~cash~~Material ~~tender~~Definitive offer (the “Tender Offer”) to acquire all of the issued and outstanding shares of common stock, par value $0.01 per share, of the Company (the “Company Shares”) at a price per share equal to $11.25, net to the seller in cash, without interest and subject to any required withholding of taxes (the “Per Share Consideration”). The Merger Agreement provides that the Tender Offer will expire 20 business days following the commencement of the Tender Offer, subject to certain extension rights and obligations set forth in the Merger Agreement, provided that Merger Sub shall not be required to extend the expiration date of the Tender Offer beyond January 31, 2011.

~~The~~ In ~~Tender~~connection ~~Offer~~with ~~is subject to a number of conditions, including, among other things: (1)~~ the ~~valid~~consummation ~~tender~~ of ~~a majority of~~ the ~~Company~~Merger, ~~Shares outstanding~~ on ~~a fully diluted basis with such shares not being withdrawn~~June 3, ~~(2)~~2010 the ~~receipt~~Company byterminated ~~Parent~~its Credit ~~and Merger Sub of the proceeds from the debt financing (or any alternative financing obtained in accordance with the terms of the Merger~~ Agreement ~~on comparable terms or terms not materially less favorable)~~, ~~(3)~~dated ~~the~~as ~~absence~~ of ~~injunctions prohibiting the Tender Offer or the Merger, (4)~~October ~~receipt of any required governmental consents and approvals~~24, ~~including the expiration or termination of any waiting period (and any extension thereof) under the Hart-Scott-Rodino Antitrust Improvements Act of 1976~~2005, as amended, ~~(5) accuracy~~among ~~of representations of~~ the Company, ~~(6) compliance~~Keybank ~~with covenants of the Company~~National Association, ~~and~~as ~~(7) the absence of a material adverse effect on the Company. Pursuant to the terms and conditions of the Merger Agreement~~lender, in the ~~event~~other ~~that~~lenders ~~all conditions to the Tender Offer are timely satisfied or waived, Parent~~ and ~~Merger~~agents ~~Sub shall be obligated to accept all Company Shares validly tendered in the Tender Offer~~thereto, ~~provided~~as ~~that more than 50%~~ of the ~~outstanding~~effective ~~Company~~time ~~Shares, calculated on a fully diluted basis, are validly tendered and not withdrawn, prior to the expiration~~ of the ~~Tender Offer~~ Merger.

~~Following~~ The ~~the~~disclosure ~~consummation~~under of the Tender Offer, and subject to the satisfaction or waiver of the conditions set forth in the Merger Agreement, Merger Sub will merge with and into the Company (the “Merger”), pursuant to which all Company Shares not acquired in the Tender Offer will be converted into the right to receive the Per Share Consideration, except for (i)Item Company Shares held by holders who comply with the relevant provisions of the Florida Business Corporation Act (“FBCA”) regarding the rights of shareholders to dissent from the Merger and require appraisal of their shares, and (ii) Company Shares held in the treasury of the Company or owned by Parent or Merger Sub5.02 ~~The closing~~ of ~~the~~this ~~Merger~~Form is subject to approval of the Merger by holders of the Company Shares; however, the parties have agreed that if after the purchase of the Company Shares pursuant to the Tender Offer and any subsequent offering period, and after giving effect to any shares purchased pursuant to the Top8-UpK Option (described below), Parent, directly or indirectly owns at least 80% of the outstanding Company Shares, then, following the satisfaction or waiver of the other conditions to the closing of the Merger, the Merger may occur in a “short-form” pursuant to applicable Florida law, which will not require the consent of the Company’s shareholders. The Merger is ~~also~~incorporated ~~conditioned~~herein ~~upon the absence of certain legal restraints and the acceptance of payment~~ by ~~Merger Sub of all the Company Shares validly tendered pursuant to the Tender Offer~~reference.

InItem ~~the~~3.01 ~~Merger~~Notice ~~Agreement,~~of ~~the~~Delisting ~~Company~~or ~~granted~~Failure to ~~Parent~~Satisfy ~~and Merger Sub an irrevocable option (the “Top-Up Option”) to purchase, at~~ a ~~per~~Continued ~~share~~Listing ~~price~~Rule ~~equal~~or toStandard; ~~the~~Transfer ~~Per Share Consideration, Company Shares equal to the number~~ of Company Shares that, when added to the number of Company Shares owned by Parent and Merger Sub at the time of exercise of the Top-Up Option, equals 80% of the Company Shares then outstanding on a fully diluted basisListing.

~~All~~ As ~~unvested~~a ~~restricted~~result ~~Company~~of ~~Shares~~the Merger, ~~options~~the ~~and~~Company ~~restricted~~no ~~stock~~longer ~~units~~fulfills ~~(“RSUs”)~~the ~~awarded~~numerical ~~under~~listing requirements of the ~~Company’s~~Nasdaq ~~incentive~~Global ~~plans~~Market ~~will~~(“Nasdaq”). ~~vest~~Accordingly, ~~upon~~on ~~consummation~~June 3, of2010, at the ~~Merger. The~~Company’s ~~holders~~request, Nasdaq offiled ~~such~~with ~~restricted~~the ~~Company~~U.S. ~~Shares~~Securities and ~~RSUs~~Exchange ~~will~~Commission ~~receive~~ (the ~~Per~~“SEC”) ~~Share~~a ~~Consideration,~~Notification ~~and~~of ~~the~~Removal from ~~holders~~Listing ofand/or ~~such~~Registration ~~options~~under ~~will~~Section ~~receive~~12(b) anof ~~amount~~the ~~equal~~Securities toExchange ~~the~~Act ~~difference~~of ~~between~~1934, ~~the~~as amended, ~~Per~~on ~~Share~~Form 25, ~~Consideration~~thereby ~~and~~effecting the ~~exercise~~delisting ~~prices~~ of ~~such~~the ~~options~~shares ~~multiplied~~of by the ~~number~~Company’s ofcommon ~~Company~~stock, $0.01 ~~Shares~~par ~~underlying~~value ~~such~~per ~~options~~share ~~held,~~from ifNasdaq ~~positive~~(the “Shares”).

The ~~Merger~~foregoing ~~Agreement~~summary ~~includes~~description ~~customary representations, warranties and covenants by the parties, including among other things a “no-shop” restriction on the ability~~ of the ~~Company~~Merger toAgreement ~~solicit~~does ~~third~~not ~~party~~purport ~~proposals relating~~ to ~~alternative~~be ~~transactions~~complete orand is toentirely ~~provide~~qualified ~~information~~by orreference ~~enter into discussions in connection with alternative transactions, subject~~ to ~~certain limited exceptions to permit~~ the ~~Company’s~~terms ~~Board~~ of ~~Directors~~the toMerger ~~comply~~Agreement, ~~with~~a ~~its~~copy ~~fiduciary duties. The Company’s Board~~ of ~~Directors~~which ~~has~~was included ~~unanimously~~as ~~approved~~Exhibit ~~the~~(d)(1) ~~Merger~~to ~~Agreement and~~ the ~~transactions contemplated thereby, including the~~ Tender Offer ~~and~~Statement ~~the~~on ~~Merger~~Schedule TO, ~~and~~filed ~~has~~by ~~resolved~~U.S. toRenal ~~recommend~~Care, Inc. ~~that~~with the ~~Company~~SEC ~~shareholders~~on ~~accept~~April 22, ~~the~~2010, ~~Tender Offer~~ and ~~tender~~which ~~their~~is ~~Company~~incorporated ~~Shares~~by inreference ~~the Tender Offer~~herein.

2 The disclosure under Items 3.03 and 5.01 of this Form 8-K is incorporated herein by reference.

~~The~~Item Merger Agreement contains certain termination rights for both the Company and Parent, including the right of the Company to terminate the Merger Agreement in the event there is a superior proposal, upon the Company’s compliance with certain notice and other specified conditions set forth in the Merger Agreement, and the right of Parent to terminate the Merger Agreement in the event of a “Company Triggering Event” (as defined in the Merger Agreement, which includes a change in the Company’s board recommendation, the Company’s board of directors fails to reaffirm its recommendation or include the recommendation in the Schedule 14D-9, or the Company breaches the “no-shop” restrictions)3. ~~The~~03 ~~Merger~~Material ~~Agreement~~Modification ~~provides that the Company would be required~~ to ~~pay~~Rights ~~Parent a termination fee~~ of ~~$2,500,000~~Security if the Merger Agreement is terminated upon certain specified events, including termination by the Company in connection with a superior proposal or termination by Parent as a result of a Company Triggering Event. In either of such cases, the Company would also be required to reimburse Parent for actual fees and expenses incurred, subject to a maximum amount of $2,000,000. The Company must pay Parent a fee of $4,500,000 if the Agreement is terminated by Parent or the Company because (A) (i) Parent has not accepted any Company Shares by January 31, 2011 or (ii) the Tender Offer is otherwise terminated or expires without Parent accepting any Company Shares, and (B)(i) at or prior to the time of such termination, an Alternative Proposal (as defined in the Merger Agreement) was disclosed, announced, committed, submitted or made and (ii) within 12 months after the date of such termination any Alternative Transaction is consummated (or a definitive agreement is entered into with such Alternative Transaction). In addition, Parent must pay the Company a fee of $6,000,000 if the Agreement is terminated by the Company as a result of a “Financing Failure” (as defined in the Merger Agreement) that prevented Parent from accepting and purchasing any Company Shares pursuant to the Tender Offer prior to the first business day that is 45 days after the Tender Offer has commenced.Holders

~~Upon~~ Pursuant ~~consummation~~to the terms of the Merger Agreement, at the ~~Company~~effective ~~will~~time noof ~~longer~~the beMerger, aeach remaining publicly ~~owned~~held ~~company;~~Share (other than Shares held by USRC, Merger Sub, the Company ~~will~~or notheir respective ~~longer~~subsidiaries) bewas ~~subject~~automatically toconverted into the ~~periodic~~right ~~disclosure~~to ~~and~~receive ~~proxy~~an ~~rules~~amount ~~promulgated~~per share byequal to $11.25 per share, net to the ~~Securities~~seller in cash, without interest thereon and ~~Exchange~~less ~~Commission~~any required withholding tax (the “~~SEC~~Offer Price”). ~~under~~Company shareholders immediately prior to the ~~Securities~~Merger ceased ~~Exchange~~to ~~Act~~have ofany ~~1934,~~rights as ~~amended,~~shareholders ~~and~~of the Company’s ~~shares~~(other ~~will~~than the right to receive the Offer Price for each of their Shares) and accordingly no longer behave ~~listed~~any orinterest ~~traded~~in on the ~~Nasdaq~~Company’s ~~Global~~future earnings ~~Market~~or growth.

The foregoing summary description of the Merger Agreement does not purport to be complete and is entirely qualified by reference to the terms of the Merger Agreement, a copy of which was included as Exhibit (d)(1) to the Tender Offer Statement on Schedule TO, filed by U.S. Renal Care, Inc. with the SEC on April 22, 2010, and ~~Voting~~which ~~Agreements~~is incorporated by reference herein.

Prior to the execution of the Merger Agreement, and as a condition and inducement to Parent and Merger Sub entering into the Merger Agreement, Parent and Merger Sub entered into Amended Employment Agreements (with certain individuals as described below under Item 5.~~02)~~01 ~~and~~Change ~~Tender~~in ~~and~~Control ~~Voting Agreements (the “Tender and Voting Agreement”) with each~~ of ~~Kenneth Bock, Thomas P~~Registrant. Carey, Stephen W. Everett, Peter D. Fischbein, Andrew J. Jeanneret, Thomas K. Langbein, Daniel R. Ouzts, Robert W. Trause and Joanne Zimmerman (each a “Shareholder”). Collectively, the Shareholders directly or indirectly own 2,236,841 Company Shares, representing approximately 23.1% of the Company Shares outstanding on the date of the Merger Agreement on a fully diluted basis.

~~Pursuant~~ On ~~to the Tender and Voting Agreements~~April 22, ~~the Shareholders have agreed~~2010, inpursuant ~~their capacity as shareholders of the Company,~~ to ~~tender or cause to be tendered to Merger Sub in~~ the ~~Tender~~terms ~~Offer all~~ of the ~~Company~~previously ~~Shares~~announced ~~owned~~Merger ~~beneficially and of record by them~~Agreement, asMerger Sub ~~well~~commenced asa ~~any~~cash ~~additional~~tender ~~Company~~offer ~~Shares which they may acquire or own, beneficially and of record~~ (the “~~Subject Shares~~Offer”)~~. The~~ ~~Shareholders also have agreed~~ to ~~vote,~~purchase ~~or caused to be voted,~~ all of ~~such~~the ~~Subject~~ Shares, inat ~~favor~~the ~~of,~~Offer ~~among other things~~Price, upon the ~~approval~~terms ofand ~~the~~subject ~~Merger~~to ~~and~~ the ~~Merger~~conditions ~~Agreement~~set ~~(and~~forth ~~against any Alternative Transaction (as defined~~ in the ~~Merger~~Offer ~~Agreement)~~to ~~and any action that could impede~~Purchase, ~~interfere~~dated ~~with~~April 22, ~~delay~~ 2010, ~~postpone,~~as ~~discourage,~~amended or ~~adversely~~supplemented ~~affect~~from ~~the~~time ~~Tender~~to ~~Offer,~~time (the ~~Merger~~“Offer ~~and~~to ~~the other transactions contemplated by the Merger Agreement~~Purchase”), and ~~have~~the ~~given~~related ~~Parent~~Letter of anTransmittal ~~irrevocable~~filed ~~proxy~~by ~~to vote each Shareholder’s Company Shares to that effect~~U. InS. ~~addition,~~Renal ~~Shareholders have agreed to waive any dissenters’ and appraisal rights they may have under applicable Florida law and have agreed not to take any action~~Care, ~~in their capacity as a shareholder of the Company, that the Company is prohibited from taking under the “no shop” restrictions included in the Merger Agreement~~Inc. ~~The~~ ~~Tender and Voting Agreement also imposed certain restrictions upon each Shareholder~~ with ~~regard, among other things,~~ the ~~transfer or granting of proxies to others to vote any or all of his or her Subject Shares~~SEC.

3 The Offer expired at 5:00 p.m., New York City time, on June 1, 2010. On June 2, 2010, USRC announced that, based on final information provided by Continental Stock Transfer & Trust Company, the Depositary for the Offer, 8,783,968 Shares (including 214,430 of such Shares tendered to the Depositary pursuant to the Offer’s guaranteed delivery procedures) were validly tendered and not withdrawn immediately prior to the expiration of the Offer, that Merger Sub has accepted such Shares for payment in accordance with the terms of the Offer and that Merger Sub will promptly pay for such Shares. USRC provided sufficient funds for Merger Sub to acquire all of the outstanding Shares. Following acceptance for payment of such Shares, USRC and Merger Sub owned approximately 90% of the outstanding Shares.

~~The~~ On ~~foregoing summaries of the Merger Agreement~~June 3, ~~the Tender and Voting Agreement~~2010, ~~and~~pursuant ~~the transactions contemplated in and by each of such agreements do not purport~~ to ~~be complete and are subject to, and qualified in their entirety by reference to,~~ the ~~full~~terms ~~text~~ of ~~each of~~ the Merger Agreement ~~and the Tender and Voting Agreement~~, ~~which~~USRC ~~are~~caused ~~attached~~Merger asSub ~~Exhibits 2(A)~~to merge ~~and~~with ~~2(B),~~ and ~~incorporated~~into ~~herein by reference. The Merger Agreement and~~ the ~~Tender~~Company ~~and~~in ~~Voting~~accordance ~~Agreement have been attached to provide investors~~ with ~~information~~Florida ~~regarding~~law, ~~their~~which ~~respective~~authorizes ~~terms. They have not been so attached with~~ the ~~intention~~completion of ~~providing any other factual information about~~ the ~~Company,~~ Merger ~~Sub~~without ora ~~Parent.~~vote ~~Certain~~or ~~representations~~meeting ~~and~~of ~~warranties in~~ the ~~Merger~~shareholders ~~Agreement were used for the purpose~~ of ~~allocating risk between~~ the Company,. onThe ~~the~~Company ~~one~~was ~~hand, and Merger Sub and Parent, on~~ the surviving ~~other~~corporation ~~hand,~~in ~~rather than establishing matters as facts. Accordingly, you should not rely on~~ the ~~representations~~Merger and ~~warranties~~continues into ~~the~~exist ~~Merger Agreement~~ as ~~characterizations~~a ofwholly ~~the~~owned ~~actual~~subsidiary ~~state~~ of ~~facts about the Company, Merger Sub or Parent~~USRC.

~~The~~ At ~~Company~~the ~~knows~~effective time of nothe ~~material~~Merger, ~~relationship~~each ~~between~~remaining publicly held Share (other than Shares held by USRC, Merger Sub, the Company or ~~its~~their ~~affiliates~~respective ~~and~~subsidiaries) ~~Parent~~was orautomatically converted into the right to receive the an amount per share equal to the Offer Price. Company shareholders immediately prior to the Merger ~~Sub~~ceased ~~other~~to have any rights as shareholders of the Company (other than ~~with~~the ~~respect~~right to receive the ~~Merger~~Offer ~~Agreement~~Price for each of their Shares) and accordingly no longer have any interest in the ~~Tender~~Company’s ~~and~~future ~~Voting~~earnings ~~Agreements~~or growth.

~~The~~ Based ~~Company and Parent issued a joint press release~~ on ~~April 14, 2010 announcing~~ the ~~execution~~Offer ofto ~~the~~Purchase ~~Merger Agreement~~ and ~~the~~subsequent ~~commencement~~“short-form” ofMerger, the ~~Tender~~per ~~Offer~~Share ~~within~~consideration of ~~seven business days~~$11.25 Aand ~~copy of~~ the ~~press~~number ~~release~~of ~~was~~outstanding ~~previously~~Shares, ~~filed on Schedule 14D-9 by~~ the ~~Company~~transaction onvalue ~~April 14, 2010 and~~ is ~~incorporated~~approximately ~~herein by reference~~$112 million.


Item 5.02		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

~~Employment~~(b) Pursuant to the previously announced Merger Agreement, ~~Amendments~~all of the Company’s existing directors resigned upon the effective time of the Merger and USRC’s designees were appointed to fill such vacancies. None of the resigning directors of the Company states that such director’s resignation related to any disagreement relating to the Company’s operation, policies and practices.

InPursuant ~~connection~~to ~~with~~ the ~~execution~~previously ofannounced ~~the~~ Merger Agreement, ~~the~~all ~~Company entered into amendments~~ of ~~its~~the ~~employment~~executive ~~agreements~~officers ~~(each, an “Amended Employment Agreement”) with Thomas K. Langbein, Stephen W. Everett and Andrew P. Carey (each, an “Executive”). Each~~ of the ~~Amended~~Company resigned ~~Employment~~immediately ~~Agreements~~prior ~~changes~~to the ~~definition~~effective time of ~~“Restricted~~the ~~Period”~~Merger and ~~changes~~ the ~~geographic~~executive ~~area~~officers ~~within~~of ~~which~~Merger Sub ~~limitations~~immediately ~~have~~prior ~~been~~to ~~imposed upon~~ the ~~Executive~~effective ~~pursuant~~time toof the ~~definition~~Merger ofremained the ~~term~~executive ~~“Restricted~~officers ~~Activities”~~of ~~as such provisions are employed in each Amended Employment Agreement. As so amended:~~the surviving

·corporation ~~the “Restricted Period” during which the non-competition provisions contained~~ in ~~each Employment Agreement shall be in effect, shall be~~ the ~~period~~Merger. ofIn ~~two~~connection ~~years~~with ~~from the Date of Termination (as~~ such ~~term is defined in the Employment Agreement)~~resignations, ~~provided,~~each ~~that if the Executive violates the noncompetition provisions~~ of the ~~Agreement,~~resigning ~~the~~officers’ employment ~~Restricted~~agreement ~~Period~~with ~~shall be extended by a period of time equal to~~ the ~~period~~Company ~~which~~was ~~begins when the violation commences and ends when the violation is~~ terminated~~; and~~.

· the geographic area which shall be applicable to the Executive noncompetition obligations shall be the within a 50 mile radius of the Company’s and its affiliates current or future dialysis facilities.

In addition to the foregoing changes, the amendment to Mr. Carey’s Amended Employment Agreement further provides that, in consideration for the changes in Mr. Carey’s noncompetition obligations, the Company shall pay $170,000 to him on the date when Parent’s designated directors are appointed to the Company’s Board, which, under the terms of the Merger Agreement, would happen upon Parent’s acceptance of any Company Shares in the Tender Offer.

This Current Report on Form 8-K is neither an offer to purchase nor a solicitation of an offer to sell securities. The tender offer for the outstanding shares of the Company’s common stock, described in this filing has not commenced. At the time the tender offer is commenced, Parent and Merger Sub will file a tender offer statement on Schedule TO with the SEC and the Company will file a solicitation/recommendation statement on Schedule 14D-9, with respect to the tender offer. The tender offer statement (including an offer to purchase, a related letter of transmittal and other offer documents) and the solicitation/recommendation statement will contain important information that should be read carefully before any decision is made with respect to the tender offer and subsequent merger. Those materials will be made available to the Company’s shareholders at no expense to them. In addition, all of those materials (and all other documents related to the tender offer and subsequent merger filed with the SEC) will be available at no charge on the SEC website at www.sec.gov.


Item 9.01		Financial Statements and Exhibits

(d) Exhibits

2.1 ~~(A)~~ Agreement and Plan of Merger, dated ~~April~~as of April 13, 2010, by and among ~~Dialysis Corporation of America,~~ U.S. Renal Care, Inc., ~~and~~ Urchin Merger Sub, Inc. ~~(Schedules~~ and ~~exhibits~~Dialysis ~~have~~Corporation ~~been~~of ~~omitted~~America ~~pursuant~~(incorporated toby ~~Item~~reference Exhibit ~~601~~(bd)(21) ofto ~~Regulation~~the ~~S-K.~~Tender ~~The~~Offer ~~Company~~Statement ~~undertakes~~on ~~to furnish~~Schedule TO, ~~supplementally,~~filed ~~copies~~with ~~of any of~~ the ~~omitted~~SEC ~~schedules and exhibits upon request~~ by ~~the~~ U.S. ~~Securities~~Renal ~~and~~Care, Inc. ~~Exchange~~on ~~Commission~~April 22, 2010).

2 (B) Form of Tender and Voting Agreement, dated April 13, 2010, by and among Dialysis Corporation of America, U.S. Renal Care, Inc., Urchin Merger Sub, Inc and various shareholders of Dialysis Corporation of America.

10 (J) First Amendment, dated as of April 13, 2010, to the Employment Agreement dated February 29, 2009 between Dialysis Corporation of America and Thomas P. Carey.

10 (K) First Amendment, dated as of April 13, 2010, to the Employment Agreement dated February 22, 2006 between Dialysis Corporation of America and Stephen W. Everett.

10 (L) First Amendment, dated as of April 13, 2010, to the Employment Agreement dated January 1, 2010 between Dialysis Corporation of America and Thomas K. Langbein.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

DIALYSIS CORPORATION OF AMERICA By /s/ Thomas L. Weinberg Thomas L. Weinberg Vice President, Secretary

~~/s/~~Dated: ~~Stephen~~June 4, ~~W. Everett~~2010

By______________________________

STEPHEN W. EVERETT

President and Chief Executive Officer

Dated: April 19, 2010

EXHIBIT INDEX

Exhibit No. 2.1 Agreement and Plan of Merger, dated as of April 13, 2010, by and among U.S. Renal Care, Inc., Urchin Merger Sub, Inc. and Dialysis Corporation of America (incorporated by reference Exhibit (d)(1) to the Tender Offer Statement on Schedule TO, filed with the SEC by U.S. Renal Care, Inc. on April 22, 2010).

2 (A) Agreement and Plan of Merger, dated April 13, 2010, by and among Dialysis Corporation of America, U.S. Renal Care, Inc. and Urchin Merger Sub, Inc. (Schedules and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company undertakes to furnish, supplementally, copies of any of the omitted schedules and exhibits upon request by the U.S. Securities and Exchange Commission)

10 (J) First Amendment, dated as of April 13, 2010, to the Employment Agreement dated February 29, 2009 between Dialysis Corporation of America and Thomas P. Carey.

10 (K) First Amendment, dated as of April 13, 2010, to the Employment Agreement dated February 22, 2006 between Dialysis Corporation of America and Stephen W. Everett.

10 (L) First Amendment, dated as of April 13, 2010, to the Employment Agreement dated January 1, 2010 between Dialysis Corporation of America and Thomas K. Langbein.

Filing Compare · DIALYSIS CORP OF AMERICA